Brief Articles
J ournal of Medicinal Chemistry, 2002, Vol. 45, No. 5 1149
4-Hyd r oxym eth yl-1,6,8-tr im eth ylfu r o[2,3-h ]qu in olin -
2(1H)-on e (13). To a solution of 12 (0.70 g, 2.3 mmol) in MeOH
(20 mL) was added a 5% methanolic KOH solution (20 mL),
and the mixture was refluxed for 1 h. The solution was diluted
with water (100 mL) and acidified with 2 N HCl. The collected
precipitate was crystallized from MeOH to give 13 (0.45 g,
76%).
A similar picture has been obtained studying skin
phototoxicity, a well-known side effect of 8-MOP; in fact,
while FQ showed a phototoxicity comparable to that of
8-MOP,9 HOFQ appeared to be incapable of inducing
erythemas on guinea pig skin.
Therefore, we can conclude that HOFQ represents a
new furoquinolinone derivative markedly more efficient
in promoting antiproliferative effects than 8-MOP and
very close to FQ.9,11 Pointing out some preliminary
interesting properties of HOFQ, including scarce geno-
toxicity and lack of skin phototoxicity, extensive studies
will be made in the future on the relationship between
the damage induced into DNA and the observed biologi-
cal effects.
Biologica l Assa ys. Detection of DNA damage, mutagen-
esis, antiproliferative activity in vitro and in vivo, and skin
phototoxicity have been recently described.10-12 For further
details, see Supporting Information.
Su p p or tin g In for m a tion Ava ila ble: Detailed procedures
for the syntheses of compounds 2 and 3; mp, NMR, and
microanalysis data for all compounds; and biological assays.
This material is available free of charge via the Internet at
http://pubs.acs.org.
Exp er im en ta l Section
Ch em istr y. TLC, mp, 1H NMR spectra, and CHN were
obtained as noted.9 See Supporting Information for synthesis
of 2 and 3, mp, NMR, and microanalysis data.
7-Allyloxy-4-m eth oxym eth yl-6-m eth ylqu in olin -2-on e (4).
A mixture of 3 (7.4 g, 34.0 mmol), allyl bromide (6.1 g, 50.4
mmol), and K2CO3 (10.0 g) in DMF (150 mL) was stirred at
20 °C for 40 h. The mixture was diluted with water (350 mL)
and the solid collected, washed with water, and crystallized
from MeOH to give 4 (2.1 g, 24%).
Refer en ces
(1) Parrish, J . A.; Stern R. S.; Pathak M. A.; Fitzpatrick T. B.
Photochemotherapy of skin diseases. In The Science of Pho-
tomedicine; Regan, J . D., Parrish J . A., Eds.; Plenum Press: New
York, 1982; pp 595-624.
(2) Gasparro, F. P. Extracorporeal Photochemoterapy-Clinical As-
pects and the Molecular Basis for Efficacy; Landes Press:
Georgetown, TX, 1994.
7-Allyloxy-1,6-d im et h yl-4-m et h oxym et h ylq u in olin -2-
on e (5) a n d 7-Allyloxy-6-m eth yl-2-m eth oxy-4-m eth oxy-
m eth ylqu in olin e (6). A mixture of 4 (5.0 g, 19.3 mmol),
dimethyl sulfate (2.8 g, 22.5 mmol), and K2CO3 (10.0 g) in
acetone (250 mL) was refluxed for 15 h. After cooling, the solid
was filtered off and the filtrate evaporated under reduced
pressure. The residue was purified by column chromatography
to give 6 (0.44 g, 8%), followed by 5 (3.5 g, 66%).
8-Allyl-1,6-d im eth yl-7-h yd r oxy-4-m eth oxym eth ylqu in -
olin -2-on e (7). A solution of 5 (3.5 g, 12.8 mmol) in N,N-
diethylaniline (50 mL) was refluxed for 7 h. After cooling, the
precipitate was collected, washed with cyclohexane, and
crystallized from AcOEt to give 7 (2.5 g, 75%).
7-Acetoxy-8-a llyl-1,6-d im eth yl-4-m eth oxym eth ylqu in -
olin -2-on e (8). A mixture of 7 (5.4 g, 19.7 mmol) and
anhydrous AcONa (1.0 g) in acetic anhydride (30 mL) was
refluxed for 1 h. The mixture was cautiously diluted with water
(600 mL), and the collected precipitate was crystallized from
AcOEt/n-hexane to give 8 (4.2 g, 68%).
(3) Kirkland, D. J .; Creed K. L.; Mannisto P. Comparative bacterial
mutagenicity studies with 8-methoxypsoralen and 4,5′,8-trim-
ethylpsoralen in the presence of near-ultraviolet light and in the
dark. Mutation Res. 1983, 116, 73-82.
(4) Hook, G. J .; Heddle J . A.; Marshall R. R. On the types of
chromosomal aberrations induced by 8-methoxypsoralen. Cyto-
genet. Cell Genet. 1983, 35, 100-103.
(5) Stern R. S.; Lange R. Members of the photochemotherapy follow-
up study. Nonmelanoma skin cancer occurring in patiens treated
with PUVA five to 10 years after first treatment. J . Invest.
Dermatol. 1988, 91, 120-124.
(6) Ben-Hur, E.; Song P. S. The photochemistry and photobiology
of furocoumarins (psoralens). Adv. Rad. Biol. 1984, 11, 131-
171.
(7) Bordin, F.; Carlassare F.; Busulini L.; Baccichetti F. Furocou-
marin sensitization induces DNA-protein cross-links. Photochem.
Photobiol. 1993, 58, 133-136.
(8) Rodighiero, P.; Guiotto A.; Chilin A.; Bordin F.; Baccichetti F.;
Carlassare F.; Vedaldi D.; Caffieri S.; Pozzan A.; Dall’Acqua, F.
Angular furoquinolinones, psoralen analogues: novel antipro-
liferative agents for skin-diseases. J . Med. Chem. 1996, 39,
1293-1302.
7-Acetoxy-8-(2′,3′-dibr om opr opyl)-1,6-dim eth yl-4-m eth -
oxym eth ylqu in olin -2-on e (9). A solution of Br2 (1.4 g, 8.9
mmol) in acetic acid (10 mL) was added dropwise to a solution
of 8 (2.8 g, 8.9 mmol) in acetic acid (60 mL) at 20 °C, and after
the addition was completed the solution was stirred for 30 min.
The solvent was evaporated under reduce pressure, and the
residue was crystallized from MeOH to give 9 (3.9 g, 92%).
4-Meth oxym eth yl-1,6,8-tr im eth ylfu r o[2,3-h ]qu in olin -
2(1H)-on e (10). A solution of KOH (2.5 g) in absolute EtOH
(50 mL) was added to a solution of 9 (3.9 g, 8.2 mmol) in
absolute EtOH (100 mL), and the mixture was refluxed for 45
min. The cooled mixture was acidified with 2 N HCl and
diluted with water (500 mL). The solid was collected, washed
with water, and crystallized from AcOEt to give 10 (1.8 g, 83%).
4-Br om om e t h yl-1,6,8-t r im e t h ylfu r o[2,3-h ]q u in olin -
2(1H)-on e (11). A mixture of 10 (1.5 g, 5.5 mmol), HBr 48%
(5 mL), and acetic acid (50 mL) was refluxed for 10 h. The
mixture was poured into water (250 mL), and the collected
precipitate was crystallized from EtOAc to give 11 (0.97 g,
55%).
(9) Bordin, F.; Marzano C.; Carlassare F.; Rodighiero P.; Guiotto
A.; Caffieri S.; Baccichetti F. Photobiological properties of a new
tetramethylfuroquinolinone. J . Photochem. Photobiol., B: Biol.
1996, 34, 159-168.
(10) Bordin, F.; Baccichetti F.; Marzano C.; Carlassare, F.; Miolo, G.;
Chilin, A.; Guiotto, A. DNA damage induced by 4,6,8,9-tetra-
methyl-2H-furo[2,3-h]quinolin-2-one, a new furocoumarin ana-
log: photochemical mechanism. Photochem. Photobiol. 2000, 71,
254-262.
(11) Marzano, C.; Baccichetti, F.; Carlassare, F.; Chilin, A.; Lora, S.;
Bordin, F. DNA damage induced by 4,6,8,9-tetramethyl-2H-furo-
[2,3-h]quinolin-2-one, a new furo-coumarin: biological conse-
quences. Photochem. Photobiol. 2000, 71, 263-272.
(12) Chilin, A.; Marzano, C.; Guiotto, A.; Manzini, P.; Baccichetti,
F.; Carlassare, F.; Bordin, F. Synthesis and biological activity
of (hydroxymethyl)- and (diethylaminomethyl)-benzopsoralens.
J . Med. Chem. 1999, 42, 2936-2945.
(13) MacLeod, J . K.; Worth, B. R.; Wells, R. J . Synthesis of benzo-
furanoid systems. Austr. J . Chem. 1978, 31, 1533-1542.
(14) Bridges, B. A.; Mottershead, R. P.; Rothwell, M. A.; Green, M.
H. L. Repair deficient bacteria strains for mutagenic screening:
test with the fungicide captan. Chem.-Biol. Interact. 1972, 5,
77-84.
4-Acet oxym et h yl-1,6,8-t r im et h ylfu r o[2,3-h ]q u in olin -
2(1H )-on e (12). Compound 12 (0.74 g, 86%) was prepared
from 11 (0.95 g, 2.9 mmol) as described for compound 8.
J M010993R